Luis Dehesa
Impact in
- Dermatology top 5%
- Dermatology and Skin Diseases
-
- Psoriasis: Treatment and Pathogenesis
- Immunotherapy and Immune Responses
Papers in
-
- Autoimmune Bullous Skin Diseases 5
-
- Histiocytic Disorders and Treatments 2
- Co-authors
- G. Carretero (11 shared papers)Francisco A. Kerdel (6 shared papers)Antonellá Tosti (1 shared paper)J. Notario (4 shared papers)F. Vanaclocha (4 shared papers)M. Ribera (4 shared papers)I. Belinchón (4 shared papers)J.C. Moreno (4 shared papers)
- Journals
- Actas Dermo-Sifiliográficas (13 papers)Pediatric Dermatology (1 paper)Dermatologic Therapy (1 paper)International Journal of Dermatology (2 papers)Annals of Dermatology (1 paper)
- Partner nations
- SpainUnited States
In The Last Decade
Luis Dehesa
23 papers receiving 348 citations
Peers
Comparison fields: 5 of 61
- Dermatology 92
- Immunology 141
- Pathology and Forensic Medicine 64
- Pharmaceutical Science 20
- Oncology 57
Countries citing papers authored by Luis Dehesa
This map shows the geographic impact of Luis Dehesa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Dehesa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Dehesa more than expected).
Fields of papers citing papers by Luis Dehesa
This network shows the impact of papers produced by Luis Dehesa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Dehesa. The network helps show where Luis Dehesa may publish in the future.
Co-authors
The 25 scholars most cited alongside Luis Dehesa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 55 | |
| 2 | 2013 | 36 | |
| 3 | 2013 | 35 | |
| 4 | 2010 | 35 | |
| 5 | The use of cyclosporine in dermatology. | 2012 | 31 |
| 6 | 2009 | 25 | |
| 7 | An Update on the Treatment of the Cutaneous Manifestations of Systemic Sclerosis: The Dermatologist's Point of View. | 2012 | 25 |
| 8 | 2012 | 21 | |
| 9 | 2009 | 18 | |
| 10 | 2018 | 11 | |
| 11 | 2018 | 9 | |
| 12 | 2015 | 8 | |
| 13 | 2007 | 7 | |
| 14 | 2010 | 6 | |
| 15 | 2011 | 5 | |
| 16 | 2008 | 5 | |
| 17 | 2013 | 5 | |
| 18 | 2011 | 5 | |
| 19 | Open label study to evaluate the efficacy of re-treatment with etanercept in patients with psoriasis. | 2012 | 4 |
| 20 | 2020 | 3 |
About Luis Dehesa
Luis Dehesa is a scholar working on Pathology and Forensic Medicine, Physiology, Immunology, Molecular Biology and Dermatology, having authored 24 papers that have together received 356 indexed citations. Recurring topics across this work include Autoimmune Bullous Skin Diseases (5 papers), Psoriasis: Treatment and Pathogenesis (5 papers), Cutaneous Melanoma Detection and Management (3 papers), Melanoma and MAPK Pathways (3 papers), Dermatologic Treatments and Research (2 papers), Retinoids in leukemia and cellular processes (2 papers), Research on Leishmaniasis Studies (2 papers) and Histiocytic Disorders and Treatments (2 papers). The work is most often cited by research in Dermatology (92 citations), Immunology (141 citations), Pathology and Forensic Medicine (64 citations), Pharmaceutical Science (20 citations) and Oncology (57 citations). Luis Dehesa has collaborated with scholars based in Spain and United States. Frequent co-authors include G. Carretero, Francisco A. Kerdel, Antonellá Tosti, J. Notario, F. Vanaclocha, M. Ribera, I. Belinchón, J.C. Moreno, L. Puig and J.M. Carrascosa. Their work appears in journals such as Actas Dermo-Sifiliográficas, Pediatric Dermatology, Dermatologic Therapy, International Journal of Dermatology and Annals of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.